Screener
Prime Medicine PRME Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
| (in thousands, except share and per share amounts) | June 30,2026 | December 31,2025 |
|---|---|---|
| Accrued expenses and other current liabilities | 8,978 | 12,600 |
| Deferred revenue — related party | 7,934 | 7,824 |
| Operating lease liability | 8,972 | 8,137 |
| Total current liabilities | 31,692 | 37,448 |
| Deferred revenue, net of current — related party | 56,033 | 58,127 |
| Operating lease liability, net of current | 103,506 | 108,290 |
| Research and development funding liability | 18,000 | 18,000 |
| Total liabilities | 209,231 | 221,865 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Prime Medicine's total current liabilities?
- Prime Medicine (PRME) reported total current liabilities of $31.69M in Q2 2026.
- How has Prime Medicine's total current liabilities changed year-over-year?
- Prime Medicine's total current liabilities decreased by 7.1% year-over-year, from $34.11M to $31.69M.
- What is the long-term trend for Prime Medicine's total current liabilities?
- Over 4 years (2021 to 2025), Prime Medicine's total current liabilities has grown at a -10.4% compound annual growth rate (CAGR), from $57.98M to $37.45M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Prime Medicine's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude